Inguinal mass: An unusual presentation of gastroesophageal junction adenocarcinoma

Inguinal mass: An unusual presentation of gastroesophageal junction adenocarcinoma

Gastroesophageal junction (GEJ) tumors are inherently aggressive owing to their location near vital structures and early lymphatic spread. The usual symptoms at presentation are dysphagia, regurgitation, and weight loss. Lymphatic involvement is seen early due to abundant submucosal lymphatics and i...

Full description

Bibliographic Details
Main Authors:	Gourav Kaushal, Santhosh Anand, Kalayarasan Raja, Sandip Chandrasekar, Biju Pottakkat, Senthil Gnanasekaran
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	International Journal of Advanced Medical and Health Research
Subjects:	Gastroesophageal junction cancer gastroesophageal junction tumor inguinal metastasis nodal metastasis unusual metastasis
Online Access:	http://www.ijamhrjournal.org/article.asp?issn=2349-4220;year=2017;volume=4;issue=2;spage=85;epage=87;aulast=Kaushal

Similar Items

Genomic Heterogeneity and Clonal Evolution in Gastroesophageal Junction Cancer Revealed by Single Cell DNA Sequencing
by: Qingke Duan, et al.
Published: (2021-05-01)

Dedifferentiated Liposarcoma of the Gastroesophageal Junction
by: Gökçe AŞKAN, et al.
Published: (2018-01-01)

Kyoto International Consensus Report on Anatomy, Pathophysiology and Clinical Significance of the Gastroesophageal Junction
by: A. A. Sheptulin, et al.
Published: (2023-12-01)

Neoadjuvant Chemoradiotherapy versus Chemotherapy for Gastroesophageal Junction Adenocarcinoma; Which Is the Optimal Treatment Option?
by: Eric Zandirad, et al.
Published: (2022-11-01)

A Case of Advanced Gastroesophageal Junction Cancer with Bulky Lymph Node Metastases Treated with Nivolumab
by: Naohiko Nakamura, et al.
Published: (2020-06-01)

Surgical Treatment of Siewert II Gastroesophagel Junction Adenocarcinoma: Esophagectomy or Gastrectomy? Review
by: Ugnė Imbrasaitė, et al.
Published: (2022-12-01)

Synchronous Gastrointestinal Stromal Tumor and Adenocarcinoma at the Gastroesophageal Junction
by: Hui-Hua Hsiao, et al.
Published: (2009-06-01)

Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer
by: Qin Liu, et al.
Published: (2023-01-01)

Role of tight junction proteins in gastroesophageal reflux disease
by: Mönkemüller Klaus, et al.
Published: (2012-09-01)

Blastic Mantle Cell Lymphoma of the Gastroesophageal Junction: A Unique Presentation and Literature Review
by: Ahmed M. Ahmed, et al.
Published: (2021-01-01)

Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era
by: Maluki Radford, et al.
Published: (2023-08-01)

Comparing Efficacy of Preoperative neo-Adjuvant Chemotherapy and Surgery versus Surgery Alone in Patients with Resectable Gastroesophageal Cancer
by: Ali Basi, et al.
Published: (2013-12-01)

Prognostic Nomogram for Postoperative Patients With Gastroesophageal Junction Cancer of No Distant Metastasis
by: Qiang Guo, et al.
Published: (2021-04-01)

Gastroesophageal flap valve reflected EGJ morphology and correlated to acid reflux
by: Chenxi Xie, et al.
Published: (2017-11-01)

Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial
by: Jodi V. Mones, et al.
Published: (2021-07-01)

Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population‐based study
by: Panpan Zhang, et al.
Published: (2018-09-01)

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer
by: Selin Aktürk Esen, et al.
Published: (2022-09-01)

Preoperative Chemoradiotherapy for Gastroesophageal Junction Adenocarcinoma Modified by PET/CT: Results of Virtual Planning Study
by: Marek Slavik, et al.
Published: (2021-12-01)

Role of palliative chemotherapy and targeted therapy in advanced esophageal and gastroesophageal junction cancers
by: Vijai Simha, et al.
Published: (2019-01-01)

The impact of preoperative waiting time in Stage II–III gastric or gastroesophageal junction cancer: A population‐based cohort study
by: Chih‐Chieh Yen, et al.
Published: (2023-08-01)

External beam radiation and high-dose-rate brachytherapy for elderly patients with gastroesophageal junction adenocarcinoma
by: Wei Zhang, et al.
Published: (2017-07-01)

Adenocarcinoma of the Gastroesophageal Junction with Synchronous Renal Cell Carcinoma: A Case Report and Literature Review
by: Yankov G., et al.
Published: (2020-09-01)

Chemotherapy Plus Atezolizumab Pre- and Post-Resection in Localized Esophageal or Gastroesophageal Junction Adenocarcinomas: A Phase I/II Single-Arm Study
by: Matheus Sewastjanow-Silva, et al.
Published: (2024-03-01)

Case Report: Pituitary metastasis as a presenting manifestation of silent gastric cardia adenocarcinoma
by: Andrea Ghezzi, et al.
Published: (2023-01-01)

Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma – significance of potentially retained stemness
by: Ju-Yoon Yoon, et al.
Published: (2020-09-01)

Identification and analysis of key genes in association with development and progression of adenocarcinoma at the gastroesophageal junction
by: WANG Yu-qian, CHEN Ya-mei, YANG Jie, LIN Yuan, LUO Ying-ying, ZHANG Shao-sen, WU Chen
Published: (2021-06-01)

Surgical treatment of the non-complicated gastroesophageal reflux: fundoplication without division of the short gastric vessels
by: FELIX Valter Nilton, et al.
Published: (2002-01-01)

Radiotherapy for tumors of the stomach and gastroesophageal junction – a review of its role in multimodal therapy
by: Buergy Daniel, et al.
Published: (2012-11-01)

Expression and Prognostic Value of RAD51 in Adenocarcinoma at the Gastroesophageal Junction
by: Darebai Redati, et al.
Published: (2022-10-01)

Independent Stage Classification for Gastroesophageal Junction Adenocarcinoma
by: Yuki Hirata, et al.
Published: (2023-10-01)

Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy
by: Attila Paszt, et al.
Published: (2023-04-01)

The impact of hiatal hernia on survival outcomes in patients with gastroesophageal junction adenocarcinoma
by: Yuya Tanaka, et al.
Published: (2022-05-01)

The Multidisciplinary Approach and Surgical Management of GE Junction Adenocarcinoma
by: Meher Oberoi, et al.
Published: (2024-01-01)

Transhiatal versus Left Transthoracic Esophagectomy for Gastroesophageal Junction Cancer; The Impact of Surgical Approach on Postoperative Complications
by: Mohammad Reza Mir, et al.
Published: (2019-04-01)

Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
by: Ratosa Ivica, et al.
Published: (2015-06-01)

Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction
by: Tilman Bostel, et al.
Published: (2024-03-01)

Conduta terapêutica atual no adenocarcinoma da cárdia e da junção esofagogástrica
by: Mauro Monteiro Correia, et al.

Tracheoesophageal fistula and esophageal perforation in a patient with advanced gastroesophageal junction tumor post ramucirumab treatment. A case report and literature review
by: Ahmed Abdalhadi, et al.
Published: (2023-03-01)

Perioperative treatment and biomarker analysis of LP002, an anti‐PD‐L1 antibody, plus chemotherapy in resectable gastric and gastroesophageal junction cancer
by: Jia‐lin Tang, et al.
Published: (2023-03-01)

Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers—A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference
by: Karen Mulder, et al.
Published: (2022-04-01)